Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer-Reference-Cited by-同舟云学术

Mutational patterns in chemotherapy resistant muscle-invasive bladder cancer

Published:2017-12 Issue:1 Volume:8 Page:
ISSN:2041-1723
Container-title:Nature Communications
language:en
Short-container-title:Nat Commun

Author:

Liu David^ORCID,Abbosh Philip,Keliher Daniel,Reardon Brendan,Miao Diana,Mouw Kent,Weiner-Taylor Amaro,Wankowicz Stephanie,Han Garam,Teo Min Yuen,Cipolla Catharine,Kim Jaegil,Iyer Gopa^ORCID,Al-Ahmadie Hikmat,Dulaimi Essel,Chen David Y. T.,Alpaugh R. Katherine,Hoffman-Censits Jean,Garraway Levi A.,Getz Gad^ORCID,Carter Scott L.,Bellmunt Joaquim,Plimack Elizabeth R.^ORCID,Rosenberg Jonathan E.,Van Allen Eliezer M.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

General Physics and Astronomy,General Biochemistry, Genetics and Molecular Biology,General Chemistry

Link

http://www.nature.com/articles/s41467-017-02320-7.pdf

Reference62 articles.

1. Reed, E. in Cancer Chemotherapy and Biotherapy: Principles and Practice 5th edn (eds Chabner B. & Longo D.) (Wolters Kluwer, 2010).

2. Emens, L. A. & Middleton, G. The interplay of immunotherapy and chemotherapy: harnessing potential synergies. Cancer Immunol. Res. 3, 436 (2015).

3. Freiha, F., Reese, J. & Torti, F. M. A randomized trial of radical cystectomy versus radical cystectomy plus cisplatin, vinblastine and methotrexate chemotherapy for muscle invasive bladder cancer. J. Urol. 155, 495–499 (1996).

4. Grossman, H. B. et al. Neoadjuvant chemotherapy plus cystectomy compared with cystectomy alone for locally advanced bladder cancer. N. Engl. J. Med. 349, 859–866 (2003).

5. von der Maase, H. et al. Long-term survival results of a randomized trial comparing gemcitabine plus cisplatin, with methotrexate, vinblastine, doxorubicin, plus cisplatin in patients with bladder cancer. J. Clin. Oncol. 23, 4602–4608 (2005).

Cited by 103 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A distinct subset of urothelial cells with enhanced EMT features promotes chemotherapy resistance and cancer recurrence by increasing COL4A1-ITGB1 mediated angiogenesis;Drug Resistance Updates;2024-09

2. Cabazitaxel as a promising therapy for cisplatin-resistant bladder cancer: a preliminary study;Medical Oncology;2024-08-06

3. Relationship between clonal evolution and drug resistance in bladder cancer: A genomic research review;Pharmacological Research;2024-08

4. Proteomic profiling identifies muscle-invasive bladder cancers with distinct biology and responses to platinum-based chemotherapy;2024-05-02

5. Development of tumor-evolution-targeted anticancer therapeutic nanomedicineEVT;Chem;2024-05